The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany.
Health Econ Rev
; 12(1): 15, 2022 Feb 14.
Article
in En
| MEDLINE
| ID: mdl-35157154
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Health_economic_evaluation
/
Risk_factors_studies
/
Screening_studies
Language:
En
Journal:
Health Econ Rev
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: